SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Oppenheimer Maintains Outperform on Ionis Pharmaceuticals, Lowers Price Target to $74

Oppenheimer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and lowers the price target from $77 to $74.

Benzinga · 05/07/2020 14:24

Oppenheimer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and lowers the price target from $77 to $74.